514 related articles for article (PubMed ID: 8771497)
21. Novel humanized anti-CD3 antibodies induce a predominantly immunoregulatory profile in human peripheral blood mononuclear cells.
Silva HM; Vieira PM; Costa PL; Pimentel BM; Moro AM; Kalil J; Maranhão AQ; Coelho V; Brigido MM
Immunol Lett; 2009 Aug; 125(2):129-36. PubMed ID: 19573559
[TBL] [Abstract][Full Text] [Related]
22. Second signal for T lymphocyte activation: multiple targets for pharmacological modulation.
Bonnefoy-Berard N; Besnard V; Morel P; Hmama Z; Verrier B; Mandrand B; Vincent C; Revillard JP
Dev Biol Stand; 1992; 77():41-8. PubMed ID: 1358733
[TBL] [Abstract][Full Text] [Related]
23. Murine antithymocyte globulin T-cell depletion is mediated predominantly by macrophages, but the Fas/FasL pathway selectively targets regulatory T cells.
Neff KS; Richards SM; Williams JM; Garman RD; Ruzek MC
Transplantation; 2011 Sep; 92(5):523-8. PubMed ID: 21804441
[TBL] [Abstract][Full Text] [Related]
24. The immunogenic potential of human fetal retinal pigment epithelium and its relation to transplantation.
Rezai KA; Semnani RT; Patel SC; Ernest JT; van Seventer GA
Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2662-71. PubMed ID: 9375586
[TBL] [Abstract][Full Text] [Related]
25. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
[TBL] [Abstract][Full Text] [Related]
26. Degree of modulation of cell-surface CD3 by anti-lymphocyte therapies.
Henell KR; Bakke A; Kenny TA; Kimball JA; Barry JM; Norman DJ
Transplant Proc; 1991 Feb; 23(1 Pt 2):1070-1. PubMed ID: 1824886
[No Abstract] [Full Text] [Related]
27. In vitro characterization of five humanized OKT3 effector function variant antibodies.
Xu D; Alegre ML; Varga SS; Rothermel AL; Collins AM; Pulito VL; Hanna LS; Dolan KP; Parren PW; Bluestone JA; Jolliffe LK; Zivin RA
Cell Immunol; 2000 Feb; 200(1):16-26. PubMed ID: 10716879
[TBL] [Abstract][Full Text] [Related]
28. CD4-mediated signals induce T cell dysfunction in vivo.
Chirmule N; Avots A; LakshmiTamma SM; Pahwa S; Serfling E
J Immunol; 1999 Jul; 163(2):644-9. PubMed ID: 10395653
[TBL] [Abstract][Full Text] [Related]
29. [In vivo use of OKT3 monoclonal antibodies in recipients of renal allografts].
Chatenoud L; Bach JF
Nephrologie; 1987; 8(3):95-8. PubMed ID: 3309702
[TBL] [Abstract][Full Text] [Related]
30. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
31. Suppression of human B cell responsiveness by CD4+ T cells does not involve CD95-CD95 ligand interactions.
Hirohata S
Cell Immunol; 1997 Nov; 181(2):182-91. PubMed ID: 9398405
[TBL] [Abstract][Full Text] [Related]
32. Roles of reactive nitrogen intermediates and transforming growth factor-beta produced by immunosuppressive macrophages in the expression of suppressor activity against T cell proliferation induced by TCR stimulation.
Shimizu T; Cai S; Tomioka H
Cytokine; 2005 Apr; 30(1):7-13. PubMed ID: 15784407
[TBL] [Abstract][Full Text] [Related]
33. Differential responses of invariant V alpha 24J alpha Q T cells and MHC class II-restricted CD4+ T cells to dexamethasone.
Milner JD; Kent SC; Ashley TA; Wilson SB; Strominger JL; Hafler DA
J Immunol; 1999 Sep; 163(5):2522-9. PubMed ID: 10452989
[TBL] [Abstract][Full Text] [Related]
34. Antithymocyte globulin impairs T-cell/antigen-presenting cell interaction: disruption of immunological synapse and conjugate formation.
Haidinger M; Geyeregger R; Poglitsch M; Weichhart T; Zeyda M; Vodenik B; Stulnig TM; Böhmig GA; Hörl WH; Säemann MD
Transplantation; 2007 Jul; 84(1):117-21. PubMed ID: 17627247
[TBL] [Abstract][Full Text] [Related]
35. Fc receptor binding of anti-CD3 monoclonal antibodies is not essential for immunosuppression, but triggers cytokine-related side effects.
Vossen AC; Tibbe GJ; Kroos MJ; van de Winkel JG; Benner R; Savelkoul HF
Eur J Immunol; 1995 Jun; 25(6):1492-6. PubMed ID: 7614975
[TBL] [Abstract][Full Text] [Related]
36. In situ antigenic modulation of human graft-infiltrating T cells is induced by OKT3 treatment.
Caillat-Zucman S; Legendre C; Noel LH; Bach JF; Kreis H; Chatenoud L
Transplant Proc; 1990 Aug; 22(4):1782. PubMed ID: 2143860
[No Abstract] [Full Text] [Related]
37. Staphylococcal enterotoxin B induces an early and transient state of immunosuppression characterized by V beta-unrestricted T cell unresponsiveness and defective antigen-presenting cell functions.
Muraille E; De Smedt T; Andris F; Pajak B; Armant M; Urbain J; Moser M; Leo O
J Immunol; 1997 Mar; 158(6):2638-47. PubMed ID: 9058796
[TBL] [Abstract][Full Text] [Related]
38. Potent apoptotic signaling and subsequent unresponsiveness induced by a single CD2 mAb (BTI-322) in activated human peripheral T cells.
Dumont C; Déas O; Mollereau B; Hebib C; Giovino-Barry V; Bernard A; Hirsch F; Charpentier B; Senik A
J Immunol; 1998 Apr; 160(8):3797-804. PubMed ID: 9558083
[TBL] [Abstract][Full Text] [Related]
39. [Immunosuppression by means of antilymphocyte serums in humans].
Revillard JP
Nouv Rev Fr Hematol; 1972; 12(2):129-37. PubMed ID: 4264610
[No Abstract] [Full Text] [Related]
40. Anti-CD3 epsilon F(ab')2 fragments inhibit T cell expansion in vivo during graft-versus-host disease or the primary immune response to nominal antigen.
Blazar BR; Jenkins MK; Taylor PA; White J; Panoskaltsis-Mortari A; Korngold R; Vallera DA
J Immunol; 1997 Dec; 159(12):5821-33. PubMed ID: 9550378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]